Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

This outcome was not met as no statistically significant difference was observed between the groups (37·6 [SD 15·2] for exenatide vs 36·6 [14·1] for placebo ... and changes in levodopa equivalent ...

Eight canines were randomized into two groups who received 0.5mg of semaglutide delivered via oral administration of the RaniPill ® HC (N=4) or subcutaneous injection (N=4). Endpoints included plasma ...

Data adds to growing body of evidence of the RaniPill® platform’s potential to enable oral delivery of multiple obesity treatments - - Phase 1 ... higher dose than the subcutaneous equivalent.

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Viking Therapeutics' painful correction has also been observed in NVO and LLY, as market sentiments surrounding GLP-1s cooled from ... % of its value or the equivalent -$1.97B of its market ...

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

He has been helping patients lose weight for more than 40 years, but says when so called GLP-1 drugs ... a lower dose is Mounjaro and they’ve got a higher dose that’s equivalent to like ...

Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

Vanessa Kanu Kanu; Executive Vice President and Chief Financial Officer; Aptargroup Inc Ladies and gentlemen, thank you for standing by. Welcome to Aptar 2024 fourth quarter and annual results ...

The first of a new generation of GLP-1 drugs was approved for weight loss ... main trade in the sector for quite a while. It is the AI equivalent of healthcare.” Ashley Oerth, associate global ...